Join our Patient Data Network
Owkin maximizes the value of your data and makes it actionable for AI
Explore our network
Hear from our partners
Why partner with Owkin?
Apply new technologies and latest AI methodologies. Harness Owkin’s multimodal data expertise. 70 publications in high impact journals.
Owkin offers access to K Pro - Owkin’s agentic AI for biology - to partners to support their research, data analysis and visualization.
World class security standards enhance patient data privacy and partner data integrity. 8+ years deploying multi-centric projects across different institutional setups.
We make your datasets visible, accessible, and actionable to drive discovery, collaboration and impact.
Identify new users, use cases, and valorisation streams, all while providing full transparency over how the data is used.
Trusted by academics
Driving value for our partners
Owkin and Hôpital Foch collaborate to test and validate biomarkers identified by Owkin's AI (through K Pro) on human tumour samples, enabling Hôpital Foch to contribute to the development of more personalized medicine.
The program maps multimodal data across 11 therapeutic areas in Owkin's extensive transatlantic network, bringing together 20 leading healthcare institutions across France, Germany, Israel, Italy, Spain, the UK, and the US, enhancing their AI expertise.
Owkin and University Hospital Vienna collaborate to advance cancer research and patient outcomes with the deployment of K Pro, Owkin’s AI copilot for biology. Hospital Vienna is pioneering agentic AI to ultimately improve outcomes for cancer patients.
Owkin and Newcastle upon Tyne Hospitals NHS Foundation Trust have entered a five-year partnership to explore how agentic AI can help advance drug discovery, development, and diagnostics - improving their foundation for AI led products.
